150 related articles for article (PubMed ID: 38461088)
21. Regression of Malignant Pleural Mesothelioma in Absence of Chemotherapy or Surgery: A Case Series.
Nief CA; No HJ; Louie CY; Vitzthum L; Das M
Clin Lung Cancer; 2023 Jan; 24(1):76-81. PubMed ID: 36323592
[No Abstract] [Full Text] [Related]
22. Re: 'High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients'.
Hara A; Matsuda M; Ishii A; Yoshioka T
Eur J Cancer; 2021 Aug; 153():265-266. PubMed ID: 34034931
[No Abstract] [Full Text] [Related]
23. Novel therapies for malignant pleural mesothelioma.
Scherpereel A; Wallyn F; Albelda SM; Munck C
Lancet Oncol; 2018 Mar; 19(3):e161-e172. PubMed ID: 29508763
[TBL] [Abstract][Full Text] [Related]
24. [The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations].
Jassem J; Biernat W; Bryl M; Chorostowska-Wynimko J; Dziadziuszko R; Krawczyk P; Kordek R; Kowalski DM; Krzakowski M; Olszewski W; Orłowski T; Ramlau R; Rzyman W
Pneumonol Alergol Pol; 2014; 82(2):133-49. PubMed ID: 24615197
[TBL] [Abstract][Full Text] [Related]
25. Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.
Lievense LA; Bezemer K; Cornelissen R; Kaijen-Lambers ME; Hegmans JP; Aerts JG
Lung Cancer; 2017 May; 107():36-40. PubMed ID: 27168021
[TBL] [Abstract][Full Text] [Related]
26. A review of bevacizumab in the treatment of malignant pleural mesothelioma.
Brosseau S; Assoun S; Naltet C; Steinmetz C; Gounant V; Zalcman G
Future Oncol; 2017 Dec; 13(28):2537-2546. PubMed ID: 29086616
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study.
Calabrò L; Morra A; Fonsatti E; Cutaia O; Fazio C; Annesi D; Lenoci M; Amato G; Danielli R; Altomonte M; Giannarelli D; Di Giacomo AM; Maio M
Lancet Respir Med; 2015 Apr; 3(4):301-9. PubMed ID: 25819643
[TBL] [Abstract][Full Text] [Related]
28. Is There Room for Second-Line Treatment of Pleural Malignant Mesothelioma?
Addeo A; Buffoni L; Di Maio M
JAMA Oncol; 2017 Sep; 3(9):1170-1171. PubMed ID: 28114625
[No Abstract] [Full Text] [Related]
29. Translational immunotherapeutics: chemoimmunotherapy for malignant pleural mesothelioma.
Adusumilli PS
Cancer; 2014 Nov; 120(21):3268-71. PubMed ID: 24989696
[No Abstract] [Full Text] [Related]
30. [Drug carrier nanosystems in malignant pleural mesothelioma].
Turgut Coşan D; Ak G; Dağ İ; Soyocak A; Dikmen G; Dal A; Güneş HV; Metintaş M
Tuberk Toraks; 2016 Mar; 64(1):60-8. PubMed ID: 27266287
[TBL] [Abstract][Full Text] [Related]
31. Re: Comments on 'High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients'.
Cantini L; Pecci F; Dammeijer F; Aerts JGJV; Berardi R
Eur J Cancer; 2021 Aug; 153():267-269. PubMed ID: 34154882
[No Abstract] [Full Text] [Related]
32. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
[TBL] [Abstract][Full Text] [Related]
33. Systemic therapy options for malignant pleural mesothelioma beyond first-line therapy: a systematic review.
Abdel-Rahman O; Kelany M
Expert Rev Respir Med; 2015 Oct; 9(5):533-49. PubMed ID: 26366804
[TBL] [Abstract][Full Text] [Related]
34. [Systemic Treatment of Malignant Pleural Mesothelioma].
Nakano T
Gan To Kagaku Ryoho; 2017 Dec; 44(13):2041-2047. PubMed ID: 29361614
[TBL] [Abstract][Full Text] [Related]
35. Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
Signorelli D; Macerelli M; Proto C; Vitali M; Cona MS; Agustoni F; Zilembo N; Platania M; Trama A; Gallucci R; Ganzinelli M; Pelosi G; Pastorino U; de Braud F; Garassino MC; Lo Russo G
Tumori; 2016; 102(1):18-30. PubMed ID: 26481865
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy for lung cancer and malignant pleural mesothelioma.
Simone CB; Cengel KA
Semin Oncol; 2014 Dec; 41(6):820-30. PubMed ID: 25499640
[TBL] [Abstract][Full Text] [Related]
37. Pemetrexed-induced painful erythematous nodules in both legs in a patient with recurrent mesothelioma.
Llamas-Velasco M; Ovejero-Merino E; Fraga J; García-Diez A; Moreno-Balsalobre R
J Cutan Pathol; 2018 Feb; 45(2):184-186. PubMed ID: 29239007
[No Abstract] [Full Text] [Related]
38. Apatinib for salvage treatment of advanced malignant pleural mesothelioma: A case report.
Du Z; Yu Y; Wu D; Zhang G; Wang Y; He L; Meng R
Medicine (Baltimore); 2018 Nov; 97(45):e13105. PubMed ID: 30407323
[TBL] [Abstract][Full Text] [Related]
39. IASLC 2020 World Conference on Lung Cancer.
Venkatesan P
Lancet Respir Med; 2020 Oct; 8(10):e76. PubMed ID: 32866439
[No Abstract] [Full Text] [Related]
40. Malignant pleural mesothelioma in a young adult with no known exposure to asbestos.
Espinosa Muñoz E; Ramírez Ocaña D; Gutiérrez Cardo AL
Arch Bronconeumol; 2016 Dec; 52(12):615-616. PubMed ID: 27156205
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
